Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

Factors associated with clinical inertia: an integrative review.

Aujoulat I, Jacquemin P, Rietzschel E, Scheen A, Tréfois P, Wens J, Darras E, Hermans MP.

Adv Med Educ Pract. 2014 May 8;5:141-7. doi: 10.2147/AMEP.S59022. eCollection 2014. Review.

PMID:
24868181
[PubMed]
Free PMC Article
2.

Can primary care team-based transition to insulin improve outcomes in adults with type 2 diabetes: the stepping up to insulin cluster randomized controlled trial protocol.

Furler JS, Young D, Best J, Patterson E, O'Neal D, Liew D, Speight J, Segal L, May C, Manski-Nankervis JA, Holmes-Truscott E, Ginnivan L, Blackberry ID.

Implement Sci. 2014 Feb 14;9:20. doi: 10.1186/1748-5908-9-20.

PMID:
24528528
[PubMed - in process]
Free PMC Article
3.

Effect of an educational toolkit on quality of care: a pragmatic cluster randomized trial.

Shah BR, Bhattacharyya O, Yu CH, Mamdani MM, Parsons JA, Straus SE, Zwarenstein M.

PLoS Med. 2014 Feb 4;11(2):e1001588. doi: 10.1371/journal.pmed.1001588. eCollection 2014 Feb.

PMID:
24505216
[PubMed - in process]
Free PMC Article
4.

Roles and relationships between health professionals involved in insulin initiation for people with type 2 diabetes in the general practice setting: a qualitative study drawing on relational coordination theory.

Manski-Nankervis JA, Furler J, Blackberry I, Young D, O'Neal D, Patterson E.

BMC Fam Pract. 2014 Jan 31;15:20. doi: 10.1186/1471-2296-15-20.

PMID:
24479762
[PubMed - in process]
Free PMC Article
5.

Clinical inertia in type 2 diabetes: A retrospective analysis of pharmacist-managed diabetes care vs. usual medical care.

Yam FK, Adams AG, Divine H, Steinke D, Jones MD.

Pharm Pract (Granada). 2013 Oct;11(4):203-10. Epub 2013 Dec 20.

PMID:
24367460
[PubMed]
Free PMC Article
6.

Determinants and consequences of insulin initiation for type 2 diabetes in France: analysis of the National Health and Wellness Survey.

Reach G, Le Pautremat V, Gupta S.

Patient Prefer Adherence. 2013 Oct 4;7:1007-23. doi: 10.2147/PPA.S51299. eCollection 2013.

PMID:
24143079
[PubMed]
Free PMC Article
7.

6(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, April 25-27, 2013, Riga, Latvia.

Alzaid A, Schlaeger C, Hinzmann R.

Diabetes Technol Ther. 2013 Dec;15(12):1033-52. doi: 10.1089/dia.2013.0260. Epub 2013 Sep 28.

PMID:
24074038
[PubMed - in process]
Free PMC Article
8.

Time and Costs of Insulin Treatment in the Care of Newly Registered Type 2 Diabetes Patients in Diabetes Clinics Across Japan (JDDM 22).

Oishi M, Yokoyama H, Abe N, Iwasaki K, Okuguchi F, Kawai K, Sugimto H, Takamura H, Takeda H, Doi K, Hirao K, Ikeda S.

Jpn Clin Med. 2011 Aug 28;2:43-51. doi: 10.4137/JCM.S7736. Print 2011.

PMID:
23885190
[PubMed]
Free PMC Article
9.

The "cost" of treating to target: cross-sectional analysis of patients with poorly controlled type 2 diabetes in Australian general practice.

Furler J, Hii JW, Liew D, Blackberry I, Best J, Segal L, Young D.

BMC Fam Pract. 2013 Mar 8;14:32. doi: 10.1186/1471-2296-14-32.

PMID:
23510207
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Saxagliptin: A Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus.

Shubrook J, Colucci R, Guo A, Schwartz F.

Clin Med Insights Endocrinol Diabetes. 2011;4:1-12. doi: 10.4137/CMED.S5114. Epub 2011 Jan 12.

PMID:
22879789
[PubMed]
Free PMC Article
11.

Grand challenges in diabetes.

Vinik A.

Front Endocrinol (Lausanne). 2012 Mar 1;3:37. doi: 10.3389/fendo.2012.00037. eCollection 2012. No abstract available.

PMID:
22649418
[PubMed]
Free PMC Article
12.

The management of type 2 diabetic patients with hypoglycemic agents.

Carnevale Schianca GP, Sola D, Rossi L, Fra GP, Bartoli E.

ISRN Endocrinol. 2012;2012:601380. doi: 10.5402/2012/601380. Epub 2012 Apr 4.

PMID:
22577575
[PubMed]
Free PMC Article
13.

The impact of adherence to screening guidelines and of diabetes clinics referral on morbidity and mortality in diabetes.

Giorda C, Picariello R, Nada E, Tartaglino B, Marafetti L, Costa G, Gnavi R.

PLoS One. 2012;7(4):e33839. doi: 10.1371/journal.pone.0033839. Epub 2012 Apr 3.

PMID:
22509263
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Strategies for initiating insulin in type 2 diabetes.

Korownyk C, Ivers N, Allan GM.

Can Fam Physician. 2011 May;57(5):562. No abstract available.

PMID:
21571718
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Multidrug treatment of type 2 diabetes: a challenge for compliance.

Miccoli R, Penno G, Del Prato S.

Diabetes Care. 2011 May;34 Suppl 2:S231-5. doi: 10.2337/dc11-s235. No abstract available.

PMID:
21525461
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Should A1C targets be individualized for all people with diabetes? Arguments for and against.

Teoh H, Home P, Leiter LA.

Diabetes Care. 2011 May;34 Suppl 2:S191-6. doi: 10.2337/dc11-s217. Review. No abstract available.

PMID:
21525454
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Evaluating the automated blood glucose pattern detection and case-retrieval modules of the 4 Diabetes Support System.

Schwartz FL, Vernier SJ, Shubrook JH, Marling CR.

J Diabetes Sci Technol. 2010 Nov 1;4(6):1563-9.

PMID:
21129354
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study.

Vitry AI, Roughead EE, Preiss AK, Ryan P, Ramsay EN, Gilbert AL, Caughey GE, Shakib S, Esterman A, Zhang Y, McDermott RA.

PLoS One. 2010 Nov 17;5(11):e14024. doi: 10.1371/journal.pone.0014024.

PMID:
21103337
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Prandial-basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia: initiate and progressively advance insulin therapy in type 2 diabetes.

Jain SM, Mao X, Escalante-Pulido M, Vorokhobina N, Lopez I, Ilag LL.

Diabetes Obes Metab. 2010 Nov;12(11):967-75. doi: 10.1111/j.1463-1326.2010.01287.x.

PMID:
20880343
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI).

Teoh H, Braga MF, Casanova A, Drouin D, Goodman SG, Harris SB, Langer A, Tan MK, Ur E, Yan AT, Zinman B, Leiter LA; T2DM QUERI Investigators.

Diabetes Care. 2010 Dec;33(12):2558-60. doi: 10.2337/dc10-0440. Epub 2010 Sep 7.

PMID:
20823344
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk